Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2022 Dec 27;90(2):208. doi: 10.1007/s12098-022-04440-5

Kikuchi Fujimoto Disease and Post–SARS-COVID-19 Association

Arvind Kumar 1, Vani Aggarwal 1, Shobhna Sharma 2, Abhishek Singhal 1, Sachin Jain 3, Seema Thakur 4,
PMCID: PMC9792312  PMID: 36572819

To the Editor: Kikuchi–Fujimoto disease (KFD) was described in 1972 by Kikuchi and Fujimoto. KFD is a benign, self-limited lymphadenitis consisting of lymphadenopathy, fever, skin rashes, arthralgia, and hepatosplenomegaly, along with elevated levels of ESR, CRP, and LDH, lymphopenia, thrombocytopenia, and leukocytosis. The various etiologies include viral infections and autoimmune diseases and recently, associations between COVID-19 and KFD were also reported. We discuss a case of KFD 6 wk after COVID-19 in a 10-y-old girl who was admitted with high-grade fever since 3 wk, bilateral, tender neck swelling, and macular rash off and on all over the body and face. There are very few case reports of associations between KFD and COVID-19 in the literature [13]. All the cases presented with fever and cervical lymphadenopathy within 2–3 mo of COVID infection. Our patient had leukopenia, anemia, and a raised ESR, similar to the cases described in the literature. All cases had raised LDH, including ours.

There is no specific diagnostic test for KFD. It is a diagnosis of exclusion. The diagnosis can be made only by histological examination of the involved lymph node and is characterized by a noncaseating necrotic area, karyorrhectic nuclear debris surrounded by mononuclear cells, particularly CD68+ histiocytes, CD123+ plasmacytoid dendritic cells, and activated CD8+ T-lymphocytes. There is no specific treatment for KFD.

We report this case to highlight this sequalae of SARS-COVID infection which will help in early diagnosis and the management of KFD.

Declarations

Conflict of Interest

None.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Jaseb K. Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S: COVID-19 in a case with Kikuchi- Fujimoto disease. Clin Case Rep. 2021;9:1279–1282. doi: 10.1002/ccr3.3748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stimson L, Stitson R, Bahhadi-Hardo M, Renaudon-Smith E. COVID-19 associated Kikuchi-Fujimoto disease. Br J Haematol. 2021;192:e124–e126. doi: 10.1111/bjh.17292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Racette SD, Alexiev BA, Angarone MP, et al. Kikuchi-Fujimoto disease presenting in a patient with SARS- CoV-2: a case report. BMC Infect Dis. 2021;21:740. doi: 10.1186/s12879-021-06048-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES